Alira Health

Welcome Daniela Sica, VP, Business Development, Pharma and Biotech

News
Published on:
December 15, 2020

BOSTON, USA – Alira Health, a leading international healthcare and life sciences advisory firm, is pleased to announce that Daniela Sica has joined the firm as Vice President, Business Development, Pharma and Biotech. Daniela has extensive experience in the pharmaceutical and biotech space, and is based out of Alira Health’s Barcelona, Spain office.

We are thrilled to welcome Daniela to the Alira Health Team,” said Benjamin Chambon, Chief Commercial Officer and EVP, Transaction Advisory. “Her notable experience in the pharma and biotech field will play a critical role in further enhancing the Alira Health lifecycle offering, and, in turn, continuing to improve synergies across our practice areas for the benefit of our clients.”
I have been following the evolution of Alira Health for several years, prior to joining the team,” said Daniela. “I have always admired the passion and commitment of the founders and leadership team, and the depth of expertise within the company. I am thrilled to join Alira Health at this exciting stage of its development.”

Daniela has over 25 years of management experience with pharmaceutical and biotech companies, and CDMOs. She has worked in business development, alliance management, and strategic planning with worldwide responsibilities, building a strong network of international relationships. Daniela has strong transaction experience, having led negotiations in co-development deals involving some of the largest global pharma companies.

Daniela sits on several biotech evaluation commissions, supporting biotech accelerators in their investment decisions. She has a degree in Food Science and Technology from the University of Milan, with a qualification as a Food Science Expert.

Learn more about our Team

Our Team

Related news

Events March 31, 2025
Swiss Biotech Day 2025
Connect with our delegates on-site to discover how we can assist you with our agile and holistic biotech solutions.
Biotech EU
Case Studies March 20, 2025
Pharma Company Defines Advocacy Strategy Through Data-Driven Patient Association Mapping
Alira Health mapped 253 CVRM patient advocacy groups across 11 countries, delivering a data-driven strategy to optimize partnerships, advocacy efforts, and differentiation.
Patient Advocacy Patient Engagement Pharma
Events March 12, 2025
Healthtech Accelerations Summit 2025
Meet our experts to discover how we support companies bring innovation to patients by structuring drug development into clear, achievable inflection points.
Biotech Drug Development EU Healthcare Technology
Case Studies March 6, 2025
Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement
A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).
Patient Centricity Pharma Rare Disease
Events February 18, 2025
BIO-Europe Spring 2025
Learn how can we support your planning, funding, and executing processes, both strategically and technically, to successfully bring your innovation to patients.
Biotech EU
Events February 17, 2025
German Biotech Days 2025
Meet us during the German Biotech Days to discuss how we can advance biotech innovation together.
Biotech EU
Articles February 17, 2025
Rethinking Rare Disease Development: An Integrated, Patient Access-Driven Approach
Explore how biotech companies can succeed in rare disease by integrating development, commercialization, and patient access.
Patient Centricity Pharma Rare Disease
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.